Comparative Analysis of Immune-based Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma

YUTA MUKAE; KOJIRO OHBA; HIROMI NAKANISHI; MASAHARU OKI; KEN KAWADA; TSUYOSHI MATSUDA; KENSUKE MITSUNARI; TOMOHIRO MATSUO; YASUSHI MOCHIZUKI; RYOICHI IMAMURA

doi:10.21873/invivo.14203

Article Information

vol. 40 no. 1 389-397

DOI

https://doi.org/10.21873/invivo.14203

PMID

41482401

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received October 24, 2025
Revision received November 10, 2025
Accepted November 13, 2025
Published online January 2, 2026.

Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

YUTA MUKAE,
KOJIRO OHBA ⇑,
HIROMI NAKANISHI,
MASAHARU OKI,
KEN KAWADA,
TSUYOSHI MATSUDA,
KENSUKE MITSUNARI,
TOMOHIRO MATSUO,
YASUSHI MOCHIZUKI and
RYOICHI IMAMURA

Department of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan

Kojiro Ohba, Department of Urology and Renal Transplantation, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Tel: +81 958197340, Fax: +81 958197343, e-mail: ohba-k{at}nagasaki-u.ac.jp

View Full Text